{
    "study_metadata": {
        "pmid": "12345678",
        "title": "Mock Study: Lenvatinib vs. Sorafenib for HCC",
        "year": 2023,
        "journal": "Journal of Mock Oncology",
        "doi": "10.1000/jmo.2023.001",
        "study_design": "RCT",
        "phase": "Phase III",
        "sample_size_total": 954,
        "arms": ["Lenvatinib", "Sorafenib"],
        "comparator": "Sorafenib"
    },
    "experiments": [
        {
            "arm_name": "Lenvatinib",
            "treatment": {
                "name": "Lenvatinib",
                "category": "Systemic",
                "line_of_therapy": "first-line",
                "duration": "Until progression or unacceptable toxicity",
                "combination": false,
                "components": null
            },
            "bclc_baseline": {
                "tumor_burden": {
                    "nodules": ">3",
                    "largest_nodule_cm": null,
                    "vascular_invasion": true,
                    "extrahepatic_spread": true,
                    "afp_ng_ml": null,
                    "afp_gt_400": null
                },
                "child_pugh": {
                    "bilirubin_mg_dl": null,
                    "albumin_g_dl": null,
                    "inr": null,
                    "ascites": null,
                    "encephalopathy": null,
                    "class_letter": "A",
                    "score": 5
                },
                "performance_status": {
                    "ecog": 1
                }
            },
            "bclc_stage_reported": "C",
            "bclc_2025_cuse": {
                "mentioned": false,
                "cuse_criteria": null,
                "personalized_factors": null,
                "decision_logic": null
            },
            "results": {
                "response_criteria": "mRECIST",
                "os": {
                    "value": "13.6 months",
                    "ci": null,
                    "p_value": null,
                    "follow_up": null
                },
                "pfs": {
                    "value": "7.4 months",
                    "ci": null,
                    "p_value": null,
                    "follow_up": null
                },
                "orr": {
                    "value": "24.1%",
                    "ci": null,
                    "p_value": null,
                    "follow_up": null
                },
                "dcr": {
                    "value": null,
                    "ci": null,
                    "p_value": null,
                    "follow_up": null
                },
                "ttp": {
                    "value": null,
                    "ci": null,
                    "p_value": null,
                    "follow_up": null
                },
                "other": null
            },
            "safety": {
                "any_adverse_events_reported": true,
                "grade_3_4_events": [
                    {
                        "name": "Hypertension",
                        "grade": null,
                        "frequency": "42%",
                        "notes": null
                    },
                    {
                        "name": "Diarrhea",
                        "grade": null,
                        "frequency": "8%",
                        "notes": null
                    }
                ],
                "saes": null,
                "discontinuation_due_to_toxicity": null,
                "treatment_related_deaths": null,
                "narrative": null
            }
        }
    ],
    "evidence_level": "high"
}
